Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2025-12-25 @ 9:43 PM
Study NCT ID:
NCT00051051
Status:
COMPLETED
Last Update Posted:
2007-05-04
First Post:
2003-01-02
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-12
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2005-05
Completion Date Type:
ACTUAL
First Submit Date:
2003-01-02
First Submit QC Date:
None
Study First Post Date:
2003-01-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2007-05-03
Last Update Post Date:
2007-05-04
Last Update Post Date Type:
ESTIMATED